• Home
    • Concept
  • Program
    • Speakers
  • Abstracts
  • On-demand
  • Location
  • Partners
  • Registration
  • Contact
    • Data Privacy Policy
    • Legal Notice
info@medupdate-europe.eu
Login

Login
Pneumo Update Europe 2025Pneumo Update Europe 2025
Pneumo Update Europe 2025
13 - 14 June - Munich & Virtual
  • Home
    • Concept
  • Program
    • Speakers
  • Abstracts
  • On-demand
  • Location
  • Partners
  • Registration
  • Contact
    • Data Privacy Policy
    • Legal Notice

Partners

More Information

Boehringer Ingelheim has over 100 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area, having launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung cancer. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.

Check here for more information about www.boehringer-ingelheim.com

More Information

Chiesi is an international group based in Parma, research-oriented, with over 85 years of experience, present in 31 countries. The Chiesi Group researches, develops and markets innovative drugs in three specific areas: AIR (products and services in the respiratory field, from infants to adults), RARE (innovative solutions and personalized services to improve the quality of life of patients with rare and ultra-rare diseases) and CARE (products and services to support specialist care, personal care and well-being).

More Information

Holistic FeNO monitoring for better asthma therapy

Bosch Healthcare Solutions offers a worldwide unique combination: FeNO measurement in medical practice and at home.

FeNO measurement can significantly improve the diagnosis and therapy of asthma. Bosch Vivatmo measures the biomarker FeNO in exhaled breath simply and precisely. The Vivatmo system consist of: Vivatmo pro – the maintenance-free FeNO measurement device for use in practice and clinic and Vivatmo me – the world’s first FeNO home measurement device for patients and studies.

Bosch Healthcare Solutions GmbH is a wholly owned subsidiary of Robert Bosch GmbH which was established in 2015.  The subsidiary’s solutions draw on the Bosch Group’s core competencies: sensors to collect data, software to evaluate that data, and services based on this data analysis. More information: www.bosch-healthcare.com, www.vivatmo-hcp.com

More Information

NIOX – The global leader in FeNO testing

NIOX is dedicated to improving the diagnosis and management of respiratory diseases such as asthma. NIOX VERO®, the gold standard FeNO testing device, is accurate, reliable and easy-to-use by physicians and patients from the age of 4.

Our unique NIOX® technology is used by healthcare professionals worldwide to accurately assess Type 2 airway inflammation. FeNO testing is non-invasive and is performed in less than 2 minutes at the point-of-care. FeNO results support healthcare professionals to achieve more accurate diagnoses and better patient outcomes.

Register Now!

Accreditation

The Pneumo Update Europe 2025 has been accredited through the European Board for Accreditation in Pneumology (EBAP) and granted 8,5 CME credits.

 

Ethical Medtech/EFPIA Compliancy

The Pneumo Update Europe 2025 has been been determined as COMPLIANT with MedTech Europe Code of Ethical Business Practice and EFPIA Code of Practice.

 

Follow us

Newsletter Subscription

Click here to receive news about your interest area. Unsubscribe at any time.

© 2025

  • Home
  • Legal Notice
  • Data Privacy Policy
  • Contact
  • Cookie policy (EU)
Manage Cookie Consent
We use cookies to optimize our website and our service. Please choose, which kind of cookies you'd like to accept.
Functional cookies Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}